Sub-Navigation

• Calendar
• Live Events
• Investor Conferences
• Stockholders' Meeting
• Press Conferences
• Roadshows
• Other Presentations
• Archive

Bayer Links

• Bayer Global
• Nachhaltigkeit
• Presse

Additionals

• General Conditions of Use
• Privacy Statement
• Imprint
• Technical Details

Klickpfad

• Home
• Events
• Archive
• Nexavar Data at ASCO 2007

June 1 - 5, 2007
Chicago, Illinois

Results from various clinical studies including a pivotal Phase III trial in patients with advanced hepatocellular carcinoma, or primary liver cancer with Nexavar® (sorafenib) tablets will be presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO).

Monday, June 4 at 2:00 p.m. CEST Investor Conference Call Review of Nexavar Data presented at ASCO 2007

On-demand audio recording of the presentation and discussion

Audio as MP3 and Podcast

Sorafenib improves survival in advanced Hepatocellular Carcinoma (HCC): Results of a Phase III randomized placebo-controlled trial (SHARP trial) - abstract LBA1

All ASCO 2007 abstracts on sorafenib

2007 ASCO Annual Meeting Program

Clinical trials information: www.clinicaltrials.gov

American Cancer Society: www.cancer.org

American National Cancer Institute: www.cancer.gov

Information on kidney cancer: www.kidneycancer.org

Information on liver cancer: www.liverfoundation.org

Information on melanoma: www.melanomainternational.org

Information on lung cancer: www.lungcancer.org

Information on cancer incidence, prevalence and mortality (GLOBOCAN): www-dep.iarc.fr